James Chafitz

James Chafitz has extensive experience in biotechnology and cancer research, having served as an Associate Scientist at SBH Sciences/Vuja De Sciences from January 2021 to January 2024, where efforts focused on identifying anti-metastasis therapies and managing various tumor cell lines. Prior to this role, James was a Senior Research Associate at Blueprint Medicines, specializing in mammalian cell maintenance and analyzing drug candidates through various assays. James's career began at Shire Pharmaceuticals as a Development Specialist, coordinating assay support for cell line development and performing a range of biochemical analyses. James holds a Bachelor of Arts in Biology from Clark University, earned between 1983 and 1987.